Literature DB >> 16756419

Methadone maintenance improves cognitive performance after two months of treatment.

Staci A Gruber1, Golfo K Tzilos, Marisa M Silveri, Mark Pollack, Perry F Renshaw, Marc J Kaufman, Deborah A Yurgelun-Todd.   

Abstract

Methadone maintenance (MM) has received little scientific attention regarding neurocognitive effects. The present study examined cognitive function in 17 opiate-dependent subjects at baseline and after 2 months of MM treatment. Subjects demonstrated significant improvements from baseline on measures of verbal learning and memory, visuospatial memory, and psychomotor speed and reduced frequency of drug use (Addiction Severity Index) relative to baseline, although the total percentage of urine samples positive for additional illicit substances was slightly increased. No effect of illicit drug use was observed when the sample was stratified by urine toxicology results, suggesting that improvements in cognition were not associated with additional illicit drug use. Results suggest that opiate-dependent subjects exhibit significant improvement in cognitive function after MM treatment. Future investigations are needed to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16756419     DOI: 10.1037/1064-1297.14.2.157

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  21 in total

Review 1.  Neuropsychological consequences of opiate use.

Authors:  Staci A Gruber; Marisa M Silveri; Deborah A Yurgelun-Todd
Journal:  Neuropsychol Rev       Date:  2007-08-10       Impact factor: 7.444

2.  Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation.

Authors:  B K Bracken; G H Trksak; D M Penetar; W L Tartarini; M A Maywalt; C M Dorsey; S E Lukas
Journal:  Drug Alcohol Depend       Date:  2012-04-30       Impact factor: 4.492

3.  Longitudinal behavioral and fMRI-based assessment of inhibitory control in heroin addicts on methadone maintenance treatment.

Authors:  Jian-Jun Ye; Wei Li; Dong-Sheng Zhang; Qiang Li; Jia Zhu; Jia-Jie Chen; Yong-Bin Li; Xue-Jiao Yan; Jie-Rong Liu; Xuan Wei; Ya-Rong Wang; Wei Wang
Journal:  Exp Ther Med       Date:  2018-08-03       Impact factor: 2.447

4.  Comparison of cognitive performance in methadone maintenance patients with and without current cocaine dependence.

Authors:  Porche K Henry; Annie Umbricht; Bethea A Kleykamp; Ryan Vandrey; Eric C Strain; George E Bigelow; Miriam Z Mintzer
Journal:  Drug Alcohol Depend       Date:  2012-01-21       Impact factor: 4.492

5.  The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.

Authors:  Allison J Applebaum; Laura C Reilly; Jeffrey S Gonzalez; Mark A Richardson; Catherine L Leveroni; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2009-06       Impact factor: 5.078

6.  Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level.

Authors:  Olga Rass; Bethea A Kleykamp; Ryan G Vandrey; George E Bigelow; Jeannie-Marie Leoutsakos; Maxine L Stitzer; Eric C Strain; Marc L Copersino; Miriam Z Mintzer
Journal:  Exp Clin Psychopharmacol       Date:  2014-02-17       Impact factor: 3.157

Review 7.  An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.

Authors:  Lisa R Norman; Michael Basso
Journal:  Curr Drug Abuse Rev       Date:  2015

Review 8.  Imaging the addicted human brain.

Authors:  Joanna S Fowler; Nora D Volkow; Cheryl A Kassed; Linda Chang
Journal:  Sci Pract Perspect       Date:  2007-04

Review 9.  The neuropsychology of amphetamine and opiate dependence: implications for treatment.

Authors:  Karen D Ersche; Barbara J Sahakian
Journal:  Neuropsychol Rev       Date:  2007-08-10       Impact factor: 7.444

10.  Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study.

Authors:  Pekka Rapeli; Carola Fabritius; Hely Kalska; Hannu Alho
Journal:  Subst Abuse Treat Prev Policy       Date:  2012-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.